Journal article
A mathematical model of Doxorubicin treatment efficacy on non-Hodgkin’s lymphoma: Investigation of current protocol through theoretical modelling results
- Abstract:
- Doxorubicin treatment outcomes for non-Hodgkin’s lymphomas (NHL) are mathematically modelled and computationally analyzed. The NHL model includes a tumor structure incorporating mature and immature vessels, vascular structural adaptation and NHL cell-cycle kinetics in addition to Doxorubicin pharmacokinetics (PK) and pharmacodynamics (PD). Simulations provide qualitative estimations of the effect of Doxorubicin on high-grade (HG), intermediate-grade (IG) and low-grade (LG) NHL. Simulation results imply that if the interval between successive drug applications is prolonged beyond a certain point, treatment will be inefficient due to effects caused by heterogeneous blood flow in the system.
Actions
Access Document
- Files:
-
-
(Preview, pdf, 1.5MB, Terms of use)
-
Authors
- Publication date:
- 2005-01-01
- UUID:
-
uuid:c1f3884e-4d16-4e79-8414-7411847cdf47
- Local pid:
-
oai:eprints.maths.ox.ac.uk:352
- Deposit date:
-
2011-05-19
- ARK identifier:
Terms of use
- Copyright date:
- 2005
If you are the owner of this record, you can report an update to it here: Report update to this record